Loading…
Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations
K-ras mutation is one of the first genetic alterations in classical colorectal carcinogenesis. To investigate the role of K-ras mutations in carcinogenesis, in long standing ulcerative colitis. A total of 161 microdissected and 100 DNA samples from 13 patients were analysed for K-ras codons 12 and 1...
Saved in:
Published in: | Gut 1999-11, Vol.45 (5), p.686-692 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | K-ras mutation is one of the first genetic alterations in classical colorectal carcinogenesis.
To investigate the role of K-ras mutations in carcinogenesis, in long standing ulcerative colitis.
A total of 161 microdissected and 100 DNA samples from 13 patients were analysed for K-ras codons 12 and 13 mutations by means of a combination of enriched polymerase chain reaction amplification and temporal temperature gradient electrophoresis.
K-ras mutations were found in 21/161 (13%) microdissected samples in 7/13 large bowels (16 and five in codons 12 and 13, respectively), and in 10/100 (10%) mucosal DNA samples (six and four, respectively). One of four patients with six adenocarcinomas had a K-ras mutation in a carcinoma, as well as one of two patients with large dysplasia associated lesion or mass (DALM). Eight of 13 (61%) areas with villous architecture and large, distended goblet cells, had a K-ras mutation, which was significantly more frequent than in low grade dysplasia (one of 23, 4%) but did not reach significance versus high grade dysplasia (four of 14, 28.5%). K-ras mutations were found in one of 20 (5%) flat lesions indefinite for dysplasia, two of 14 (14%) in non-villous, hypermucinous mucosa, and in one of 57 flat areas negative for dysplasia.
The highest K-ras mutation frequency was found in villous, hypermucinous mucosa. We suggest that this entity should be investigated further as a potential risk lesion for cancer development. It may represent a pathway directly from non-classical dysplasia to cancer, not previously described. |
---|---|
ISSN: | 0017-5749 1468-3288 1458-3288 |
DOI: | 10.1136/gut.45.5.686 |